Witness Testimony

Dr. Matthew Cockle testified that Canadian universities and national research bodies failed to provide balanced debate and public scrutiny during the COVID-19 response. He argued that institutions traditionally seen as guardians of the public good instead aligned with predetermined research priorities shaped through global coalitions such as GloPID-R, the World Health Organization, and related funding networks. He highlighted substantial funding directed toward vaccine readiness and uptake initiatives prior to the availability of randomized clinical trial data, raising concerns about conflict of interest and the influence of pharmaceutical stakeholders in shaping Canada’s research agenda.
He further contended that public–private partnerships between national research institutions and global funding bodies eroded independent governance and transparency. He described Canadian Institutes of Health Research initiatives as closely coordinated with international research roadmaps that prioritized vaccine development, while alternative therapeutic research received comparatively less emphasis. He maintained that such coordination limited open scientific debate and fostered a culture in which researchers deferred to centralized authority rather than critically examining policy decisions.
Dr. Cockle also criticized what he characterized as increasing legislative centralization and regulatory restructuring in British Columbia, including changes under the Health Professions and Occupations Act and emergency-related measures. He expressed concern that unelected bodies could alter professional standards and definitions without meaningful public consultation. Concluding, he argued that the growing normalization of specialized authority and deference to expert institutions reduced civic responsibility and public oversight, thereby weakening democratic accountability and enabling coercive policy implementation.